Discontinuation of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis and Psoriasis

被引：0

作者：

Wolfe, Sophia ^{[1
]}

Cheng, Elizabeth ^{[2
]}

Ganuthula, Kavya ^{[1
,3
]}

Fang, Meika

Kerr, Gail ^{[4
]}

Walsh, Jessica ^{[5
]}

Chang, Elizabeth ^{[6
]}

Raychaudhuri, Siba ^{[7
]}

Brees, Kyle ^{[2
]}

Dellavalle, Robert ^{[1
]}

Reimold, Andreas ^{[8
]}

Caplan, Liron ^{[1
]}

机构：

[1] Univ Colorado, Sch Med, Rocky Mt Reg VAMC, Aurora, CO USA

[2] Rocky Mt Reg VAMC, Aurora, CO USA

[3] UCLA, David Geffen Sch Med, West Angeles Vet Affairs Med Ctr VAMC, Los Angeles, CA USA

[4] Georgetown & Howard Univ, Washington DC Vet Affairs Med Ctr VAMC, Washington, DC USA

[5] Univ Utah Hosp, Salt Lake City Veteran Affairs Med Ctr VAMC, Salt Lake City, UT USA

[6] Phoenix VAMC, Phoenix, AZ USA

[7] Univ Calif Davis Hlth, Sacramento Vet Affairs Med Ctr VAMC, Davis, CA USA

[8] Univ Texas SouthWestern Med Ctr Dallas, Dallas Vet Affairs Med Ctr VAMC, Dallas, TX USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1830

引用

页码：3825 / 3827

页数：3

共 50 条

[1] Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis
Krueger, G
Callis, K
[J]. ARCHIVES OF DERMATOLOGY, 2004, 140 (02) : 218 - 225
[2] Tumor necrosis factor inhibitors in psoriatic arthritis
Mantravadi, Santhi
Ogdie, Alexis
Kraft, Walter K.
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 899 - 910
[3] Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis
Fantuzzi, Francesca
Del Giglio, Micol
Gisondi, Paolo
Girolomoni, Giampiero
[J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (09) : 1085 - 1096
[4] SECONDARY EFFICACY FAILURE IS THE PREDOMINANT ETIOLOGY FOR DISCONTINUATION OF TUMOR NECROSIS FACTOR INHIBITOR IN PSORIASIS/PSORIATIC ARTHRITIS
Wolfe, S.
Cheng, E.
Brees, K.
Caplan, L.
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A16 - A16
[5] TUMOR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
Vieira-Sousa, E.
Eusebio, M.
Avila-Ribeiro, P.
Khmelinskii, N.
Machado, A. R.
Martins-Rocha, T.
Bernardes, M.
Santos-Faria, D.
Leite Silva, J.
Santos, H.
Miguel, C.
Carvalho, P.
Costa, T.
Teixeira, L.
Meirinhos, T.
Nero, P.
Santos, M. J.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 731 - 732
[6] Anti-tumor necrosis factor α therapy in psoriatic arthritis and psoriasis
Girolomoni, G
Abeni, D
[J]. ARCHIVES OF DERMATOLOGY, 2001, 137 (06) : 784 - 785
[7] Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis
Agarwal, Sandeep K.
Glass, Roberta J.
Shadick, Nancy A.
Coblyn, Jonathan S.
Anderson, Ronald J.
Maher, Nancy E.
Weinblatt, Michael E.
Solomon, Daniel H.
[J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1737 - 1744
[8] Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab
Cauza, E
Spak, M
Cauza, K
Hanusch-Enserer, U
Dunky, A
Wagner, E
[J]. RHEUMATOLOGY INTERNATIONAL, 2002, 22 (06) : 227 - 232
[9] Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab
Edmund Cauza
Marita Spak
Karla Cauza
Ursula Hanusch-Enserer
Attila Dunky
Ernst Wagner
[J]. Rheumatology International, 2002, 22 : 227 - 232
[10] Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists
Wu, Chun-Ying
Chang, Yun-Ting
Juan, Chao-Kuei
Shen, Jui-Lung
Lin, Yu-Pu
Shieh, Jeng-Jer
Liu, Han-Nan
Chen, Yi-Ju
[J]. MEDICINE, 2016, 95 (22)

← 1 2 3 4 5 →